Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
02:09
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

52nd ERA-EDTA Congress

 

28-31 May 2015 London
FAQs
   
Discussion forum - 52nd ERA-EDTA Congress
    Topic - J4) Chronic Kidney Disease. Anaemia.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
ASSOCIATION OF OUTCOMES AND MAINTENANCE OF TARGET HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 23 PROSPECTIVE STUDIES  Danilo Fliser 1      6/1/2015 5:31:00 PM  
ASSOCIATION OF OUTCOMES AND HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 24 PROSPECTIVE STUDIES  Francesco Locatelli 1      6/1/2015 5:29:00 PM  
DUODENAL IRON AFTER FERRIC CITRATE ADMINISTRATION IN UREMIC RATS  Noemi Vergara Segura 1      5/18/2015 7:27:00 PM  
INFLUENCE OF NUTRITIONAL STATUS ON ANEMIA TREATMENT IN CROATIAN PERITONEAL DIALYSIS PATIENTS: A MULTICENTRE STUDY  Josipa Radi&263; 1      5/18/2015 5:28:00 PM  
DOES TWO INTRAVENOUS IRON FORMULATIONS INDUCE DIFFERENT ACUTE EFFECTS IN NON-DIALYSIS CKD PATIENTS?  Cristina Capusa 1      5/18/2015 12:12:00 PM  
IS LOW VITAMIN D LEVEL AN INFLAMMATORY MEDIATOR OF ANAEMIA IN KIDNEY TRANSPLANTATION?  Winnie Chan 1      5/15/2015 10:12:00 PM  
PHARMACOKINETICS OF TRIFERIC ADMINISTERED IV TO HEALTHY VOLUNTEERS: NO EFFECT ON HEPCIDIN OR OXIDATIVE STRESS MARKERS.  Raymond Pratt 1      5/15/2015 7:50:00 PM  
STRUCTURAL, PHYSICAL AND FUNCTIONAL CHARACTERISATION OF FERRIC PYROPHOSPHATE CITRATE (FPC, TRIFERIC), A NOVEL IRON COMPOUND FOR PHARMACEUTICAL APPLICATIONS  Gupta Ajay 1      5/15/2015 7:23:00 PM  
TRIFERIC HAS A SAFETY PROFILE SIMILAR TO PLACEBO: AN INTEGRATED SAFETY ANALYSIS OF PHASE 2 AND 3 STUDIES.  Ajay Gupta 1      5/15/2015 6:49:00 PM  
JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS  Tadao Akizawa 1      5/15/2015 7:56:00 AM  
ERYPTOSIS INDUCED BY INDOXYL SULFATE IS RELATED TO OXIDATIVE STRESS.  Andrea N Moreno-Amaral 1      5/14/2015 8:35:00 PM  
MODERATE HEPATIC IMPAIRMENT HAS ONLY A MINOR IMPACT ON THE PHARMACOKINETICS OF ROXADUSTAT, AN ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL-HYDROXYLASE INHIBITOR  Marloes Schaddelee 1      5/14/2015 5:40:00 PM  
       




Most viewed poster for this congress
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal

Poster most viewed in this topic
Poster: 380
Visits: 225
Title: JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
Authors: Tadao Akizawa ,
Centre: Showa University School of Medicine, Division of Nephrology, Department of Medicine


 






PosterSessionOnline
Logo Draft
 
Logo Cert